Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $5.3 million.

  • Pediatrix Medical's Capital Expenditures fell 1513.51% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.6 million, marking a year-over-year decrease of 3987.19%. This contributed to the annual value of $22.0 million for FY2024, which is 3392.34% down from last year.
  • Latest data reveals that Pediatrix Medical reported Capital Expenditures of $5.3 million as of Q3 2025, which was down 1513.51% from $4.5 million recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Capital Expenditures registered a high of $10.5 million during Q3 2021, and its lowest value of $3.2 million during Q4 2021.
  • Moreover, its 5-year median value for Capital Expenditures was $7.0 million (2024), whereas its average is $6.9 million.
  • In the last 5 years, Pediatrix Medical's Capital Expenditures soared by 18592.17% in 2022 and then tumbled by 6196.37% in 2024.
  • Pediatrix Medical's Capital Expenditures (Quarter) stood at $3.2 million in 2021, then skyrocketed by 185.92% to $9.1 million in 2022, then fell by 0.15% to $9.0 million in 2023, then crashed by 61.96% to $3.4 million in 2024, then surged by 55.17% to $5.3 million in 2025.
  • Its last three reported values are $5.3 million in Q3 2025, $4.5 million for Q2 2025, and $3.3 million during Q1 2025.